Liposomal cytarabine for central nervous system embryonal tumors in children and young adults

Gurney JG, Smith MA, Bunin GR (1999) CNS and miscellaneous intracranial and intraspinal neoplasms. In: Ries LAG, Smith MA, Gurney JG et al (eds) Cancer Incidence and Survival Among children and Adolescents: United States SEER Program 1975–1995, National Cancer Institute, SEER Program. NIH Pub. No. 99–4649, Bethesda, MD

Blaney SM, Boyett J, Friedman H, Gajjar A, Geyer R, Horowtiz M et al (2005) Phase I clinical trial of mafosfamide in infants and children aged 3 years or younger with newly diagnosed embryonal tumors: a pediatric brain tumor consortium study (PBTC-001). J Clin Oncol 23(3):525–531

Shapiro WR, Young DF, Mehta BM (1975) Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular, and lumbar injections. N Engl J Med 293(4):161–166

Strong JM, Collins JM, Lester C, Poplack DG (1986) Pharmacokinetics of intraventricular and intravenous N,N’,N”-triethylenethiophosphoramide (thiotepa) in rhesus monkey and humans. Cancer Res 46(12 Pt 1):6101–6104

Zimm S, Collins JM, Miser J, Chatterji D, Poplack DG (1984) Cytosine arabinoside cerebrospinal fluid kinetics. Clin Pharmacol Ther 35(6):826–830

Kim S, Chatelut E, Kim JC, Howell SB, Cates C, Kormanik PA et al (1993) Extended CSF cytarabine exposure following intrathecal administration of DTC 101. J Clin Oncol 11(11):2186–2193

Glantz MJ, LaFollette S, Jaeckle KA, Shapiro W, Swinnen L, Rozental JR et al (1999) Randomized trial of slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis. J Clin Oncol 17(10):3110–3116

Glantz MJ, Jaeckle KA, Chamberlain MC, Phuphanich S, Recht L, Swinnen LJ et al (1999) A randomized controlled trial comparing intrathecal sustained-release cytarabine (Depocyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors. Clin Cancer Res 5(11):3394–3402

Cole BF, Glantz MJ, Jaeckle KA, Chamberlain MC, Mackowiak JI (2003) Quality-of-life-adjusted survival comparison of sustained-release cytosine arabinoside versus intrathecal methotrexate for treatment of solid tumor neoplastic meningitis. Cancer 97(12):3053–3060

Lassaletta A, Perez-Olleros P, Scaglione C, Sirvent S, De Prada I, Perez-Martinez A et al (2007) Successful treatment of intracranial ependymoma with leptomeningeal spread with systemic chemotherapy and intrathecal liposomal cytarabine in a two-year-old child. J Neurooncol 83(3):303–306

Chamberlain MC, Glantz MJ (2008) Sequential salvage chemotherapy for recurrent intracranial hemangiopericytoma. Neurosurgery 63(4):720–727

Bomgaars L, Geyer JR, Franklin J, Dahl G, Park J, Winick NJ et al (2004) Phase I trial of intrathecal liposomal cytarabine in children with neoplastic meningitis. J Clin Oncol 22(19):3916–3921

Benesch M, Siegler N, Hoff K, Lassay L, Kropshofer G, Müller H et al (2009) Safety and toxicity of intrathecal liposomal cytarabine (Depocyte) in children and adolescents with recurrent or refractory brain tumors: a multi-institutional retrospective study. Anticancer Drugs 20(9):794–799

Grossman SA, Finkelstein DM, Ruckdeschel JC, Trump DL, Moynihan T, Ettinger DS (1993) Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. J Clin Oncol 11(3):561–569

Fisher PG, Kadan-Lottick NS, Korones DN (2007) Intrathecal thiotepa: reappraisal of an established therapy. J Pediatr Hematol Oncol 24(4):274–278

Blaney SM, Heideman R, Berg S, Adamson P, Gillespie A, Geyer JR et al (2003) Phase I clinical trial of intrathecal topotecan in patients with neoplastic meningitis. J Clin Oncol 21(1):143–147

Groves MD, Glantz MJ, Chamberlain MC, Baumgartner KE, Conrad CA, Hsu S et al (2008) A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies. Neuro-Oncol 10(2):208–215

Bernardi RJ, Bomgaars L, Fox E, Balis FM, Egorin MJ, Lagattuta TF et al (2008) Phase I clinical trial of intrathecal gemcitabine in patients with neoplastic meningitis. Cancer Chemother Pharmacol 62(2):355–361

Blaney SM, Balis FM, Berg S, Arndt CA, Heideman R, Geyer JR et al (2005) Intrathecal mafosfamide: a preclinical pharmacology and phase I trial. J Clin Oncol 23(7):1555–1563

Gururangan S, Petros WP, Poussaint TY, Hancock ML, Phillips PC, Friedman HS et al (2006) Phase I trial of intrathecal spartaject busulfan in children with neoplastic meningitis: a Pediatric Brain Tumor Consortium Study (PBTC-004). Clin Cancer Res 12(5):1540–1546

Lassaletta A, Lopez-Ibor B, Mateos E, Gonzalez-Vicent M, Perez-Martinez A, Sevilla J et al (2009) Intrathecal liposomal cytarabine in children under 4 years with malignant brain tumors. J Neurooncol 95(1):65–69

Pui C (2007) Toward optimal use of intrathecal liposomal cytarabine. Leuk Lymphoma 48(9):1672–1673